Agitation,Psychomotor
25
5
6
12
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
12.0%
3 terminated out of 25 trials
80.0%
-6.5% vs benchmark
24%
6 trials in Phase 3/4
42%
5 of 12 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 12 completed trials
Clinical Trials (25)
Electroconvulsive Therapy (ECT) for Agitation in Dementia (AD)
Clinical Trial on Agitation in Alzheimer's Dementia
Cannabidiol Solution for the Treatment of Behavioral Symptoms in Older Adults With Mild Cognitive Impairment or Alzheimer's Dementia
Tachyphylaxis, Tolerance, & Withdrawal Post Treatment With Igalmi for Agitation in Schizophrenia or Bipolar Disorder
Observational Study Evaluating the Safety of ADASUVE® in Agitation Associated With Schizophrenia or Bipolar I Disorder
Dexmedetomidine in the Treatment of Agitation Associated With Schizophrenia and Bipolar Disorder (SERENITY III)
A Multicomponent Intervention Program to Prevent and Reduce ICU Agitation and Physical Restraint Use
Outcomes of Antipsychotic Medication Used in the Emergency Department
Effects of Dexmedetomidine on Agitation in Critically Ill TBI Patients
Dronabinol for Agitation in Dementia Crossover Trial
A Medical Cannabis Oil for Treatment of Agitation and Disruptive Behaviors in Subjects With Dementia.
Safe Brain Initiative, Operationalizing Precision Anaesthesia
Agitation Follow up After Introduction of a New Patient Care Algorithm
Physical Restraints in Intensive Care Unit Patients
Assessing Clinical Outcomes in Alzheimer's Disease Agitation
Sub-Lingual Dexmedetomidine in Agitation Associated With Dementia
Addressing Dementia Via Agitation-Centered Evaluation
Dexmedetomidine in the Treatment of Agitation Associated With Bipolar Disorder
The Effect of Intraoperative Magnesium Sulfate Infusion on the Occurrence of Emergence Agitation
CAlming Touch for People With Agitation or Other Behavioural Symptoms of DEMentia - A Randomized Feasibility Trial